<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0136">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0136">
  <string-name>
   <surname>Pillaiyar</surname>, 
   <given-names>T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Manickam</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Namasivayam</surname>, 
   <given-names>V.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hayashi</surname>, 
   <given-names>Y.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Jung</surname>, 
   <given-names>S. H.</given-names>
  </string-name> (
  <year>2016</year>). 
  <article-title>An overview of severe acute respiratory syndrome‐coronavirus (SARS‐CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy</article-title>. 
  <source xml:lang="en">Journal of Medicinal Chemistry</source>, 
  <volume>59</volume>(
  <issue>14</issue>), 
  <fpage>6595</fpage>–
  <lpage>6628</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01461</pub-id>
  <pub-id pub-id-type="pmid">26878082</pub-id>
 </mixed-citation>
</ref>
